Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder
William Yang Wang, Nora D. Volkow, QuangQiu Wang, Nathan A. Berger, Pamela B. Davis, David C. Kaelber, Rong Xu
Abstract
This cohort study uses emulation target trial methods to evaluate whether semaglutide is associated with lower rates of opioid overdose among patients with type 2 diabetes (T2D) and opioid use disorder (OUD).
Topics & Concepts
Opioid use disorderType 2 diabetesMedicineOpioidSemaglutideOpioid overdoseDiabetes mellitusInternal medicineEndocrinology(+)-NaloxoneLiraglutideReceptorDiabetes Treatment and ManagementPharmaceutical Practices and Patient OutcomesMedication Adherence and Compliance